Identification of DNA methylation patterns predisposing for an efficient response to BCG vaccination in healthy BCG-naïve subjects

Epigenetics. 2019 Jun;14(6):589-601. doi: 10.1080/15592294.2019.1603963. Epub 2019 Apr 22.

Abstract

The protection against tuberculosis induced by the Bacille Calmette Guérin (BCG) vaccine is unpredictable. In our previous study, altered DNA methylation pattern in peripheral blood mononuclear cells (PBMCs) in response to BCG was observed in a subgroup of individuals, whose macrophages killed mycobacteria effectively ('responders'). These macrophages also showed production of Interleukin-1β (IL-1β) in response to mycobacterial stimuli before vaccination. Here, we hypothesized that the propensity to respond to the BCG vaccine is reflected in the DNA methylome. We mapped the differentially methylated genes (DMGs) in PBMCs isolated from responders/non-responders at the time point before vaccination aiming to identify possible predictors of BCG responsiveness. We identified 43 DMGs and subsequent bioinformatic analyses showed that these were enriched for actin-modulating pathways, predicting differences in phagocytosis. This could be validated by experiments showing that phagocytosis of mycobacteria, which is an event preceding mycobacteria-induced IL-1β production, was strongly correlated with the DMG pattern.

Keywords: BCG-vaccination; DNA methylation; Mycobacterium tuberculosis; Tuberculosis; actin regulation; phagocytosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BCG Vaccine / administration & dosage*
  • Base Sequence
  • DNA Methylation*
  • Gene Expression Profiling
  • Healthy Volunteers
  • Humans
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism*
  • Leukocytes, Mononuclear / microbiology
  • Macrophages / immunology
  • Macrophages / metabolism*
  • Macrophages / microbiology
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / immunology*
  • Sequence Homology
  • Tuberculosis / immunology*
  • Tuberculosis / microbiology
  • Tuberculosis / prevention & control
  • Vaccination

Substances

  • BCG Vaccine

Grants and funding

This work was supported by the Hjärt-Lungfonden [20130685]; Hjärt-Lungfonden [20150709]; Vetenskapsrådet [2015-02593]; Vetenskapsrådet [2012-3349].